Gemcitabine-mediated tumour regression and p53-dependent gene expression: implications for colon and pancreatic cancer therapy

Gemcitabine is a chemotherapeutic that is widely used for the treatment of a variety of haematological malignancies and has become the standard chemotherapy for the treatment of advanced pancreatic cancer. Combinational gemcitabine regimes (e.g.with doxorubicin) are being tested in clinical trials t...

Descripción completa

Detalles Bibliográficos
Autores principales: Hill, R, Rabb, M, Madureira, P A, Clements, D, Gujar, S A, Waisman, D M, Giacomantonio, C A, Lee, P W K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789167/
https://www.ncbi.nlm.nih.gov/pubmed/24008735
http://dx.doi.org/10.1038/cddis.2013.307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789167/
https://www.ncbi.nlm.nih.gov/pubmed/24008735
http://dx.doi.org/10.1038/cddis.2013.307

Ejemplares similares